SCHEMBL27372125

SCHEMBL27372125

Cc1cccc(C2CCC(C(F)(F)F)CC2)c1C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 4/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ TAS1R3 Q7RTX0 1/20 0.35
▸ TAS1R1 Q7RTX1 1/20 0.35
▸ TAS1R2 Q8TE23 1/20 0.35
▸ TERT O14746 1/20 0.34
▸ NOD2 Q9HC29 1/20 0.34
▸ NOD1 Q9Y239 1/20 0.34
▸ NOTUM Q6P988 1/20 0.33
▸ PLAT P00750 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ GRM6 O15303 1/20 0.33
▸ MAPK7 Q13164 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ RBP4 P02753 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27371832 0.83 SCN9A (0.34) MEN1KMT2AATMTERTSCN9A
SCHEMBL27378973 0.82 MEN1 (0.38) HTR2CMEN1KMT2AATMTRPV1
SCHEMBL27362608 0.82 ADRA1A (0.35) MEN1KMT2AATMTERTSCN9A
SCHEMBL27373991 0.81 CACNA1F (0.45) MEN1KMT2AATMLMNAHTT
SCHEMBL30755397 0.81 MYC (0.39) HTR2CMEN1KMT2AATMTRPV1
SCHEMBL27373688 0.81 MYC (0.39) HTR2CMEN1KMT2AATMTRPV1
SCHEMBL30755130 0.78 ALOX5AP (0.47) MEN1KMT2AATMTRPV1TERT
SCHEMBL15724450 0.74 GRM6 (0.46) MEN1KMT2AATMGRM6CYP2C9
SCHEMBL27372143 0.73 TRPV1 (0.36) KMT2ATRPV1GRM6LMNACYP3A4
SCHEMBL30755538 0.72 NOD2 (0.36) TRPV1TAS1R3TAS1R1TAS1R2TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4562016-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME Cedilla Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
WO-2024026483-A2 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback